Literature DB >> 9317117

Down-regulation of the expression and function of the transporter associated with antigen processing in murine tumor cell lines expressing IL-10.

F Salazar-Onfray1, J Charo, M Petersson, S Freland, G Noffz, Z Qin, T Blankenstein, H G Ljunggren, R Kiessling.   

Abstract

The MHC class I molecules present antigenic peptides to CTL. The peptides are delivered to the secretory pathway by TAP, which is formed by the association of MHC-encoded TAP1 and TAP2 gene products. Tumor cells incubated or transfected with IL-10 had decreased but peptide-inducible expression of MHC class I, decreased sensitivity to MHC class I-restricted CTL, and increased NK sensitivity. We here demonstrate that IL-10 expression in the murine lymphoma RMA inhibits the TAP-dependent translocation of peptides to the endoplasmic reticulum, resulting in accumulation of immature MHC class I molecules in the endoplasmic reticulum and subsequently low expression of cell surface MHC class I molecules. This finding is explained by a down-regulation of expression of TAP1 and TAP2, observed in IL-10-transfected RMA cells as well as in IL-10-transfected P815 mastocytoma cells. In the J558L plasmacytoma cell line, constitutively expressing high levels of IL-10, increased TAP-dependent translocation of peptides and expression of cell surface MHC class I could be induced by IL-10 antisense expression. IL-10 is the first example to demonstrate that a cytokine can decrease the expression and function of the TAP1/2 molecular complex and, in more general terms, the first example of a cytokine with an inhibitory effect on MHC class I-mediated Ag presentation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9317117

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  13 in total

Review 1.  Interleukin-10: a cytokine used by tumors to escape immunosurveillance.

Authors:  F Salazar-Onfray
Journal:  Med Oncol       Date:  1999-07       Impact factor: 3.064

2.  Modulation of virus-induced delayed-type hypersensitivity by plasmid DNA encoding the cytokine interleukin-10.

Authors:  E Manickan; M Daheshia; N Kuklin; S Chun; B T Rouse
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 3.  Natural selection of tumor variants in the generation of "tumor escape" phenotypes.

Authors:  Hung T Khong; Nicholas P Restifo
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

4.  Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes.

Authors:  A D Santin; P L Hermonat; A Ravaggi; S Bellone; S Pecorelli; J J Roman; G P Parham; M J Cannon
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

5.  Deficiency of activated STAT1 in head and neck cancer cells mediates TAP1-dependent escape from cytotoxic T lymphocytes.

Authors:  Michael S Leibowitz; Pedro A Andrade Filho; Soldano Ferrone; Robert L Ferris
Journal:  Cancer Immunol Immunother       Date:  2011-01-05       Impact factor: 6.968

Review 6.  NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections.

Authors:  Raymond M Welsh; Stephen N Waggoner
Journal:  Virology       Date:  2013-01-05       Impact factor: 3.616

7.  Localization, expression change in PRRSV infection and association analysis of the porcine TAP1 gene.

Authors:  Nunu Sun; Dewu Liu; Hongbo Chen; Xiangdong Liu; Fanming Meng; Xianwei Zhang; Huiyong Chen; Shengsong Xie; Xinyun Li; Zhenfang Wu
Journal:  Int J Biol Sci       Date:  2011-11-17       Impact factor: 6.580

8.  A race between tumor immunoescape and genome maintenance selects for optimum levels of (epi)genetic instability.

Authors:  Shingo Iwami; Hiroshi Haeno; Franziska Michor
Journal:  PLoS Comput Biol       Date:  2012-02-16       Impact factor: 4.475

Review 9.  Transplant tolerance: new insights and strategies for long-term allograft acceptance.

Authors:  Paulina Ruiz; Paula Maldonado; Yessia Hidalgo; Alejandra Gleisner; Daniela Sauma; Cinthia Silva; Juan Jose Saez; Sarah Nuñez; Mario Rosemblatt; Maria Rosa Bono
Journal:  Clin Dev Immunol       Date:  2013-05-12

10.  Cross-presentation of cell-associated antigens by mouse splenic dendritic cell populations.

Authors:  Robert I Thacker; Edith M Janssen
Journal:  Front Immunol       Date:  2012-03-14       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.